George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.90
Bid: 153.40
Ask: 153.70
Change: 0.70 (0.46%)
Spread: 0.30 (0.196%)
Open: 155.00
High: 162.30
Low: 151.50
Prev. Close: 151.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Aston Martin Lagonda Gbl Hld plc

31 Jul 2019 10:27

RNS Number : 3650H
JPMorgan Securities Plc
31 July 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aston Martin Lagonda Global Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker to Aston Martin Lagonda Global Holdings plc

(d) Date dealing undertaken:

30 July 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

Ordinary Share

Purchase

 

Sale

261,221

 

176,448

5.9291 GBP

 

5.9040 GBP

5.5386 GBP

 

5.5420 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

Equity Swap

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

 

 

 

 

1,946

1,472

1,375

1,099

701

2,380

37,471

4,745

4,415

482

2,895

200

500

16,235

9,031

651

779

24,794

1,680

566

44

1,623

5

 

2,651

3,860

10,161

500

23,175

3,071

2,010

4,446

75,000

956

2,885

1,092

69,912

5.6166 GBP

5.6354 GBP

5.6440 GBP

5.6530 GBP

5.6536 GBP

5.6562 GBP

5.6800 GBP

5.6809 GBP

5.6868 GBP

5.6880 GBP

5.6936 GBP

5.7112 GBP

5.7418 GBP

5.7543 GBP

5.7606 GBP

5.7635 GBP

5.7839 GBP

5.8075 GBP

5.8478 GBP

5.8564 GBP

5.8662 GBP

5.8789 GBP

5.9038 GBP

 

5.5525 GBP

5.5650 GBP

5.6522 GBP

5.6659 GBP

5.6800 GBP

5.6803 GBP

5.6839 GBP

5.6977 GBP

5.7296 GBP

5.7601 GBP

5.8214 GBP

5.8301 GBP

5.8935 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Ordinary Share

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

31 July 2019

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGCGDRUDXBGCB
Date   Source Headline
14th Sep 20229:49 amRNSHolding(s) in Company
14th Sep 20229:46 amRNSHolding(s) in Company
14th Sep 20227:00 amRNSRights Issue offer period amended
13th Sep 20229:00 amRNSHolding(s) in Company
12th Sep 20227:00 amRNSAdmission of Nil Paid Rights
9th Sep 20227:00 amRNSAdmission of placing shares & total voting rights
8th Sep 202211:32 amRNSResult of General Meeting
5th Sep 202212:28 pmRNSPublication of Prospectus
5th Sep 20227:00 amRNS4 for 1 c.£575.8 million Rights Issue
22nd Aug 20227:00 amRNSCircular and Notice of General Meeting
29th Jul 20227:00 amRNSHalf-year Report
15th Jul 20227:00 amRNSProposed New Equity Financing and Investment
1st Jul 20223:37 pmRNSHolding(s) in Company
1st Jul 202211:38 amRNSHolding(s) in Company
30th Jun 20223:31 pmRNSStatement Regarding Media Commentary
20th Jun 20221:20 pmRNSCompany Secretary Change
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
25th May 202212:04 pmRNSResult of AGM
11th May 20227:00 amRNSHolding(s) in Company
4th May 20227:01 amRNS1st Quarter Results
4th May 20227:00 amRNSAppointment of New Chief Executive Officer
3rd May 20227:00 amRNSNew Chief Financial Officer Joins Board
28th Apr 20223:14 pmRNSHolding(s) in Company
25th Apr 20222:08 pmRNSNotice of AGM
20th Apr 202212:19 pmRNSDirector Declaration
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:02 amRNSChief Financial Officer Board Appointment Date
14th Mar 20227:00 amRNSPublication of 2021 Annual Report and Accounts
28th Feb 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSDirectorate Change
7th Jan 20227:00 amRNSFY 2021 Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 202110:01 amRNSDirector/PDMR Shareholding
2nd Dec 20213:07 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirectorate Change
1st Dec 202110:19 amRNSAdditional Listing
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 202110:30 amRNSDirector/PDMR Shareholding
8th Nov 202110:49 amRNSDirector/PDMR Shareholding
4th Nov 20217:05 amRNSResults for the nine months to 30 September 2021
29th Oct 202110:02 amRNSTotal Voting Rights
1st Oct 202112:08 pmRNSTotal Voting Rights
31st Aug 202110:37 amRNSTotal Voting Rights
12th Aug 202110:58 amRNSDirector/PDMR Shareholding
3rd Aug 20212:35 pmRNSDirector/PDMR Shareholding
29th Jul 202110:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.